Effects of nitric oxide synthase inhibitors on cocaine sensitization

Brain Research

Volumn 746, Issue 1-2, 1997, Pages 183-189

  Haracz, John L ^a   MacDonall, James S ^b   Sircar, Ratna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

Behavioral sensitization; Cocaine; Drug abuse; Nitric oxide; Stereotypy; Stimulant

Indexed keywords

7 NITROINDAZOLE; COCAINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; ENZYME INHIBITORS; INDAZOLES; MALE; N-METHYLASPARTATE; NARCOTICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 0031028161     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01193-6     Document Type: Article

References (56)

1. Ahmed, S.H., Cador, M., Le Moal, M. and Stinus, L., Amphetamine-induced conditioned activity in rats: comparison with novelty-induced activity and the role of the basolateral amygdala, Behav. Neurosci., 109 (1995) 723-733.
2. Carey, R.J. and Gui, J., Extinction can eliminate cocaine conditioned behavior but leave cocaine sensitization intact, Soc. Neurosci. Abstr., 22 (1996) 931.
3. Carmona, G.N., Goldberg, S.R. and Schindler, C.W., Pharmacological sensitization to cocaine depends on similarity between injection and testing conditions, Soc. Neurosci. Abstr., 22 (1996) 931.
4. Dwyer, M.A., Bredt, D.S. and Snyder, S.H., Nitric oxide synthase: irreversible inhibition by L-Nω-nitroarginine in brain in vitro and in vivo, Biochem. Biophys. Res. Commun., 176 (1991) 1136-1141.
5. Ehrman, R.N., Robbins, S.J., Childress, A.R. and O'Brien, C.P., Conditioned responses to cocaine-related stimuli in cocaine abuse patients, Psychopharmacology (Berlin), 107 (1992) 523-529.
6. Fukuto, J.M. and Chaudhuri, G., Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition, Annu. Rev. Pharmacol. Toxicol., 35 (1995) 165-194.
7. Haracz, J.L., Belanger, S.A., MacDonall, J.S. and Sircar, R., Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization, Life Sci., 57 (1995) 2347-2357.
8. Haracz, J.L., Belanger, S.A., MacDonall, J.S. and Sircar, R., Nitric oxide and NMDA receptor involvement in sensitization to cocaine-induced behavioral activation, Soc. Neurosci. Abstr., 21 (1995) 712.
9. Haracz, J.L., Tschanz, J.T., Wang, Z., White, I.M. and Rebec, G.V., Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats, Neurosci. Biobehav. Rev., 17 (1993) 1-12.
10. Hecker, M., Mulsch, A. and Busse, R., Subcellular localization and characterization of neuronal nitric oxide synthase, J. Neurochem., 62 (1994) 1524-1529.
11. Ida, I., Asami, T. and Kuribara, H., Inhibition of cocaine sensitization by MK-801, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice, Jpn. J. Pharmacol., 69 (1995) 83-90.
12. Itzhak, Y., Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice, Neuropharmacology, 32 (1993) 1069-1070.
13. Itzhak, Y., Modulation of the PCP/NMDA receptor complex and a binding sites by psychostimulants, Neurotoxicol. Teratol., 16 (1994) 363-368.
14. Itzhak, Y., Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors, Pharmacol. Toxicol., 74 (1994) 162-166.
15. Itzhak, Y., Cocaine kindling in mice: responses to N-methyl-D,L-aspartate (NMDLA) and L-arginine, Mol. Neurobiol., 11 (1995) 217-222.
16. Itzhak, Y. and Norenberg, M.D., Inhibition of brain nitric oxide synthase modulates the behavioral sensitization to cocaine and methamphetamine, Soc. Neurosci. Abstr., 22 (1996) 1932.
17. Kalivas, P.W. and Alesdatter, J.E., Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine, J. Pharmacol. Exp. Ther., 267 (1993) 486-495.
18. Karler, R., Calder, L.D. and Bedingfield, J.B., Cocaine behavioral sensitization and the excitatory amino acids, Psychopharmacology (Berlin), 115 (1994) 305-310.
19. Karler, R., Calder, L.D. and Bedingfield, J.B., A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice, Brain Res., 725 (1996) 192-198.
20. Karler, R., Calder, L.D., Chaudhry, I.A. and Turkanis, S.A., Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801, Life Sci., 45 (1989) 599-606.
21. Karler, R., Calder, L.D., Thai, L.H. and Bedingfield, J.B., A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine, Brain Res., 658 (1994) 8-14.
22. Karler, R., Calder, L.D. and Turkanis, S.A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552 (1991) 295-300.
23. Kim, H.-S. and Park, W.-K., Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice, J. Pharmacol. Exp. Ther., 275 (1995) 551-557.
24. Kuribara, H., Asami, T., Ida, I., Iijima, Y. and Tadokoro, S., Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine, Psychopharmacology (Berlin), 108 (1992) 271-275.
25. LeDuc, B.W., Sinclair, P.R., Walton, H.S., Sinclair, J.F., Greenblatt, D.J. and Shuster, L., Cocaine toxicity in cultured chicken hepatocytes: role of cytochrome P450, Toxicol. Appl. Pharmacol., 125 (1994) 322-332.
26. MacKenzie, G.M., Rose, S., Bland-Ward, P.A., Moore, P.K., Jenner, P. and Marsden, C.D., Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole, NeuroReport, 5 (1994) 1993-1996.
27. Moncada, S., Palmer, R.M.J. and Higgs, E.A., Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43 (1991) 109-142.
28. Montague, P.R., Gancayco, C.D., Winn, M.J., Marchase, R.B. and Friedlander, M.J., Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex, Science, 263 (1994) 973-977.
29. Noda, Y., Yamada, K., Komori, Y., Sugihara, H., Furukawa, H. and Nabeshima, T., Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice, Br. J. Pharmacol., 117 (1996) 1579-1585.
30. Ohkuma, S., Katsura, M., Guo, J.-L., Hasegawa, T. and Kuriyama, K., Involvement of peroxynitrite in N-methyl-D-aspartate- and sodium nitroprusside-induced release of acetylcholine from mouse cerebral cortical neurons, Mol. Brain Res., 31 (1995) 185-193.
31. Ohno, M. and Watanabe, S., Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice, Eur. J. Pharmacol., 275 (1995) 39-44.
32. Pellinen, P., Honkakoski, P., Stenback, F., Niemitz, M., Alhava, E., Pelkonen, O., Lang, M.A. and Pasanen, M., Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors, Eur. J. Pharmacol. - Environ. Toxicol. Pharmacol., 270 (1994) 35-43.
33. Perino, L.E., Warren, G.H. and Levine, J.S., Cocaine-induced hepatotoxicity in humans, Gastroenterology, 93 (1987) 176-180.
34. Pert, A., Post, R. and Weiss, S.R.B., Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. In: L. Erinoff (Ed.), Neurobiology of Drug Abuse: Learning and Memory. National Institute on Drug Abuse Research Monograph 97, US Government Printing Office, Washington, DC, 1990, pp. 208-241.
35. Post, R.M., Lockfeld, A., Squillace, K.M. and Contel, N.R., Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization, Life Sci., 28 (1981) 755-760.
36. Przewlocka, B., Lason, W., Machelska, H. and Przewlocki, R., The effects of cocaine-induced seizures on the proenkephalin mRNA level in the mouse hippocampus: a possible involvement of the nitric oxide pathway, Neurosci. Lett., 168 (1994) 81-84.
37. Pudiak, C.M. and Bozarth, M.A., L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine, Life Sci., 53 (1993) 1517-1524.
38. Rebec, G.V., Ruble, L.A. and White, I.M., Cocaine increases striatal single-unit activity in freely moving rats, Soc. Neurosci. Abstr., 19 (1993) 1855.
39. Reith, M.E.A., Benuck, M. and Lajtha, A., Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice, J. Pharmacol. Exp. Ther., 243 (1987) 281-287.
40. Salter, M., Duffy, C., Garthwaite, J. and Strijbos, P.J.L.M., Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of Nω-nitro-L-arginine (L-NA) and its methyl ester (L-NAME), Neuropharmacology, 34 (1995) 639-649.
41. Satel, S.L., Southwick, S.M. and Gawin, F.H., Clinical features of cocaine-induced paranoia, Am. J. Psychiatry, 148 (1991) 495-498.
42. Schmidt, H.H.H.W., Hofmann, H. and Ogilvie, P., Regulation and dysregulation of constitutive nitric oxide synthases types I and III. In: H. Koprowski and H. Maeda (Eds.), The Role of Nitric Oxide in Physiology and Pathophysiology, Springer, Berlin, 1995, pp. 75-86.
43. Schuman, E.M. and Madison, D.V., Nitric oxide and synaptic function, Annu. Rev. Neurosci., 17 (1994) 153-183.
44. Sircar, R., Rappaport, M., Nichtenhauser, R. and Zukin, S.R., The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/σ-receptor, Brain Res., 435 (1987) 235-240.
45. Stewart, J., Deschamps, S.-E. and Amir, S., Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine, Brain Res., 641 (1994) 141-144.
46. Stewart, J. and Druhan, J.P., Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801, Psychopharmacology (Berlin), 110 (1993) 125-132.
47. Vincent, S.R. and Kimura, H., Histochemical mapping of nitric oxide synthase in the rat brain, Neuroscience, 46 (1992) 755-784.
48. Weihmuller, F.B., O'Dell, S.J., Cole, B.N. and Marshall, J.F., MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study, Brain Res., 549 (1991) 230-235.
49. Weiss, S.R.B., Post, R.M., Pert, A., Woodward, R. and Murman, D., Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression, Pharmacol. Biochem. Behav., 34 (1989) 655-661.
50. Wise, R.A. and Hoffman, D.C., Localization of drug reward mechanisms by intracranial injections, Synapse, 10 (1992) 247-263.
51. Wolf, M.E., Dahlin, S.L., Hu, X.-T., Xue, C.-J. and White, K., Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists, Neuroscience, 69 (1995) 417-439.
52. Wolf, M.E. and Jeziorski, M., Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization, Brain Res., 613 (1993) 291-294.
53. Wolf, M.E., White, F.J. and Hu, X.-T., MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine, J. Neurosci., 14 (1994) 1735-1745.
54. Wolff, D.J. and Gribin, B.J., The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents, Arch. Biochem. Biophys., 311 (1994) 300-306.
55. Xu, X. and Domino, E.F., Phencyclidine-induced behavioral sensitization, Pharmacol. Biochem. Behav., 47 (1994) 603-608.
56. Zhang, J. and Snyder, S.H., Nitric oxide in the nervous system, Annu. Rev. Pharmacol. Toxicol., 35 (1995) 213-233.